Jubilant Life Sciences Ltd :

158.85 0.10 [0.06%]

ISIN: INE700A01033 | NSE: JUBILANT | Industry: Pharmaceuticals - Indian - Bulk Drugs | BSE Code: 530019 | Comments

Price Information
• Open	160.00
• High	161.95
• Low	158.55
• Previous Close	158.75
• Shares Traded	6413
• 52 Wk High Price	248.25
• 52 Wk High Date	10-12-2012
• 52 Wk Low Price	154.00
• 52 Wk Low Date	06-08-2012
• Face Value	1.00

Fundamentals
• Market Capital (Rs.cr)	2528.89
• EPS (Rs.)(TTM)	4.90
• P/E Ratio(TTM)	32.40
• Book Value (Rs.)	116.90
• Price to Book Value	1.36
• Equity (Rs.cr.)	15.93
• Traded Value (Rs.lac)	16.37

Corporate Actions
Ex-Date	Purpose (Rs.)
2011-08-10	200% Dividend (2)
2012-08-14	300% Dividend (3)

Related Companies
Stock Name	Price

DILLTD	453.00
GUJLYKAMERGE	15.65	-
GUJTHEMIS	12.22	-
SHRISHMAFINE	0.42	-
REGENTCHEMICALS	2.00	-
CHEMDRUGSMERGE	440.00	-
CHEMOXCHEMICAL	1.10	-
ALPHADRUG	38.65	-
SEQUENTSCIENTIFIC	150.05
VINATIORGA	110.25

Share Tips for Jubilant Life Sciences Ltd

SUPER DUPER PROFIT FOR SUBSCRIB (11:34AM, May 18 '13)

Our Positional Jackpot Tatasteel Futur (09:36AM, May 06 '13)

Grab Tech Mahindra and Jubilant Food F (11:42AM, May 03 '13)

SELL Jubilant Foodworks Ltd. Intraday (10:30AM, Apr 11 '13)

buy buy buy jetairways : BUY jetairways (01:48PM, Feb 14 '13)

Mutual funds holding in Jubilant Life Sciences Ltd

Taurus Starshare Fund - Growth

SBI Magnum Sector Umbrella - Emerging Businesses Fund - Growth

Escorts Growth Plan - Growth

SBI Magnum Sector Umbrella - Pharma Fund - Growth

Baroda Pioneer Monthly Income Fund - Growth

Key Financials	Latest Qrtr.	Trailing Yr.	Full Yr.
• Year End	Mar, 2013	Mar, 2013	Mar, 2013
• Sales (Rs.cr)	840.66	3124.85	3124.85
• Net Profit (Rs.cr)	-5.52	78.69	78.69
• Net Profit Var (%)	72.00	23.00	23.00
• EPS (Rs)	-	4.90	4.90
• P/E Ratio	-	32.40	32.40
• Operating Profit Margin	-	14.50	-
• CPS (Rs.)	-	-	14.50
• P/C Ratio	-	-	11.00
• Div%	-	-	300.00

Announcements
06-04-2013	Hamidulla K Khan ceases as director of Jubilant
06-07-2011	Jag Mohan Khanna ceases as director of Jubilant Life Sciences
19-11-2010	Jubilant Life Sciences allots equity shares
25-10-2011	Jubilant Life Sciences grants options
08-05-2013	Jubilant Life Sciences Recommeds Dividend
08-05-2012	Jubilant Life Sciences recommends dividend
28-04-2012	Jubilant Life Sciences to announce financial results
04-02-2011	Jubilant Life Sciences to announce Q3 results
21-09-2012	Jubilant receives USFDA approvals for 4 dosage formulations in CVS and CNS therapeutic areas
13-08-2011	Jubilant signs a long term supply agreement for a new product
15-09-2011	Jubilant signs contract to manufacture an OTC women health product

Gross Deliverables

Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover

17-05-2013 3699 6413 57.68 587586 1023.87
13-05-2013 9127 15045 60.66 1481768 2437.91
11-05-2013 1245 1559 79.86 200507 251.34
10-05-2013 8515 13132 64.84 1376876 2135.57
03-05-2013 1060 1890 56.08 187461 337.89

Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action

Comment(s) posted on Jubilant Life Sciences Ltd

Hot Searches • ador • gallantt • whirlpool • capsu • data • renuka • colgate • rallis • escorts • moserbaer

Date	Del. Shares	Trd. Qty.	Del.(%)	Del. Value	Turnover
17-05-2013	3699	6413	57.68	587586	1023.87
13-05-2013	9127	15045	60.66	1481768	2437.91
11-05-2013	1245	1559	79.86	200507	251.34
10-05-2013	8515	13132	64.84	1376876	2135.57
03-05-2013	1060	1890	56.08	187461	337.89